HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the founders and shareholders Dr. Peter Schlanstein, Dr. Matthias Menne and Niklas Steuer. Before founding the company, they worked together for many years at the Institute for Applied Medical Technology (AME) at RWTH Aachen University and are highly specialized in their fields.
inContAlert was founded in September 2022 within the ecosystem of the University of Bayreuth. The MedTech startup's sensor system empowers patients with neurogenic bladder dysfunction to manage their bladder on a needs-based basis.
Sedivention is developing a medical device for a new therapy of obesity. The Blizzard cryocatheter freezes the nerve branches, that transmit an increased, inadequate feeling of hunger to the brain in obese people, from inside the stomach. The hunger feeling is reduced in a one-off, minimally invasive intervention, similar to a gastroscopy. Our aim is to help obese people lose weight and thus reduce their risk of secondary diseases such as diabetes, hypertension and cancer. And we do this without surgery, without implants, without lifelong medication.
